Skip to main content
IQVIAPatent grant

IQVIA was granted a patent for predicting psychiatric relapse risk.

Source: Autobound Signal API · 71 signals tracked for IQVIA · updated

Get IQVIA's live signals in Claude or ChatGPT, or by API

AskWhat changed at IQVIA this week? Use Autobound signals for iqvia.com.

What happened

In October 2026 IQVIA patented an assessment method for identifying psychiatric relapse or onset risk in clinical research and care settings.

Source

patents.google.comOct 27, 2026

US patent US12776337

Method for predicting risk of relapse or onset of a psychiatric condition

Abstract

A method includes, for each user in a population: audio recording the user reciting a story configured to elicit an emotion associated with a psychiatric condition; concurrently recording a set of biosignals of the user; generating a set of psychophysiological markers correlating instances of the emotion and the set of biosignals; assessing a clinical assessment for the condition in the user; correlating the set of psychophysiological markers and the clinical assessment; and compiling the correlations into a model configured to predict risk of condition onset in a user. The method also includes: accessing a series of biosignals of a first user; identifying a series of psychophysiological markers in the series of biosignals; based on the series of psychophysiological markers and the model, calculating a risk of onset of the condition in the first user; and, in response to the risk exceeding a threshold, serving the notification to the first user.

patents.google.com/patent/US12776337Read the full source

Extracted by Autobound

From the Signal API record
Signal
Patent grant

What this signalsA new patent often shows where a company is putting its R&D budget.

Grant date
Oct 27, 2026
Inventors
3
Tech area
speech / audio AI
Patent number
US12776337

The full record

From the Signal API record

People

  • Georgios EleftheriouInventor
  • Panagiotis FatourosInventor
  • Charalampos TsirmpasInventor

Details

Primary CPC class
G10L 25/63 (Speech analysis or synthesis; speech/voice recognition; audio coding)
USPTO assignee
IQVIA Inc.
What the invention does
A system that analyzes a person’s emotional storytelling and simultaneous body signals, then compares the resulting patterns with clinical evaluations to estimate psychiatric risk.

Topics and mentions

Tags

  • Intellectual Property
  • Research & Development
  • Healthcare Technology
  • Artificial Intelligence
  • Language Technology

Technologies named

  • speech analysis
  • biosignal monitoring
  • psychophysiology
  • clinical assessment

Extraction

Detected
Oct 30, 2026
signal_type
patents-company
signal_subtype
patentGrant

Use this data

Get every patent signal for IQVIA and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at IQVIA this week?”

  2. Send it to your own tools

    The Signal API returns patent signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full patents-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/5c6ad0d3-7693-5225-b7c0-4ed299a26eec returns this record as JSON. POST /v1/companies/enrich returns every signal for iqvia.com.

{
  "signal_id": "5c6ad0d3-7693-5225-b7c0-4ed299a26eec",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-10-30T00:44:12+00:00",
  "company": {
    "name": "IQVIA",
    "domain": "iqvia.com"
  },
  "data": {
    "cpc": [
      {
        "code": "G10L 25/63",
        "label": "Speech analysis or synthesis; speech/voice recognition; audio coding"
      },
      {
        "code": "G06F 11/327",
        "label": "Electric digital data processing"
      },
      {
        "code": "G06V 40/20",
        "label": "Image or video recognition or understanding"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Healthcare Technology",
      "Artificial Intelligence",
      "Language Technology"
    ],
    "detail": "In October 2026 IQVIA patented an assessment method for identifying psychiatric relapse or onset risk in clinical research and care settings.",
    "summary": "IQVIA was granted a patent for predicting psychiatric relapse risk.",
    "event_at": "2026-10-27",
    "inventors": [
      {
        "name": "Georgios Eleftheriou",
        "status": "unresolved",
        "is_primary": true
      },
      {
        "name": "Panagiotis Fatouros",
        "status": "unresolved",
        "is_primary": false
      },
      {
        "name": "Charalampos Tsirmpas",
        "status": "unresolved",
        "is_primary": false
      }
    ],
    "tech_area": "speech / audio AI",
    "event_kind": "grant_date",
    "grant_date": "2026-10-27",
    "source_url": "https://patents.google.com/patent/US12776337",
    "cpc_primary": {
      "code": "G10L 25/63",
      "label": "Speech analysis or synthesis; speech/voice recognition; audio coding"
    },
    "patent_title": "Method for predicting risk of relapse or onset of a psychiatric condition",
    "patent_number": "US12776337",
    "uspto_assignee": "IQVIA Inc.",
    "patent_abstract": "A method includes, for each user in a population: audio recording the user reciting a story configured to elicit an emotion associated with a psychiatric condition; concurrently recording a set of biosignals of the user; generating a set of psychophysiological markers correlating instances of the emotion and the set of biosignals; assessing a clinical assessment for the condition in the user; correlating the set of psychophysiological markers and the clinical assessment; and compiling the correlations into a model configured to predict risk of condition onset in a user. The method also includes: accessing a series of biosignals of a first user; identifying a series of psychophysiological markers in the series of biosignals; based on the series of psychophysiological markers and the model, calculating a risk of onset of the condition in the first user; and, in response to the risk exceeding a threshold, serving the notification to the first user.",
    "precision_class": "structural",
    "invention_explanation": "A system that analyzes a person’s emotional storytelling and simultaneous body signals, then compares the resulting patterns with clinical evaluations to estimate psychiatric risk.",
    "technologies_mentioned": [
      "speech analysis",
      "biosignal monitoring",
      "psychophysiology",
      "clinical assessment"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.